Ventyx Biosciences Inc

NAS:VTYX (USA)  
$ 5.48 -0.305 (-5.25%) 11:09 PM EST
At Loss
P/B:
1.33
Market Cap:
$ 385.94M
Enterprise V:
$ 168.76M
Volume:
1.97M
Avg Vol (2M):
5.38M
Volume:
1.97M
At Loss
Avg Vol (2M):
5.38M

Business Description

Description
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
Name Current Vs Industry Vs History
Cash-To-Debt 20.17
Equity-to-Asset 0.88
Debt-to-Equity 0.05
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -39
3-Year EPS without NRI Growth Rate -111.1
3-Year FCF Growth Rate -113.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 11
9-Day RSI 29.09
14-Day RSI 40.18
6-1 Month Momentum % -77.97
12-1 Month Momentum % -77.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.87
Quick Ratio 11.87
Cash Ratio 11.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -41
Shareholder Yield % -13.16

Financials (Next Earnings Date:2024-05-10 Est.)

VTYX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VTYX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ventyx Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.3
Beta 0
Volatility % 270.56
14-Day RSI 40.18
14-Day ATR ($) 0.834408
20-Day SMA ($) 7.8255
12-1 Month Momentum % -77.49
52-Week Range ($) 1.865 - 40.58
Shares Outstanding (Mil) 70.43

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ventyx Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Ventyx Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Ventyx Biosciences Inc Frequently Asked Questions

What is Ventyx Biosciences Inc(VTYX)'s stock price today?
The current price of VTYX is $5.48. The 52 week high of VTYX is $40.58 and 52 week low is $1.87.
When is next earnings date of Ventyx Biosciences Inc(VTYX)?
The next earnings date of Ventyx Biosciences Inc(VTYX) is 2024-05-10 Est..
Does Ventyx Biosciences Inc(VTYX) pay dividends? If so, how much?
Ventyx Biosciences Inc(VTYX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1